A new study evaluates the use of Extracorporeal shockwave therapy in musculoskeletal disorders

August 14, 2023

ESWT (Extracorporeal Shockwave Therapy) is a novel non-invasive regenerative therapy used in various musculoskeletal disorders. It has shown promising results in chronic tendinopathies such as Achilles Tendinopathy, Plantar Fasciopathy, Patellar Tendinopathy, and Proximal Hamstrings Tendinopathy. The success rates reported in studies have varied from 65% to 91%, making it an effective treatment option for these conditions.

One significant advantage of ESWT is its relatively low complication rate, which is generally considered negligible. This makes it a safer alternative to surgery for certain orthopaedic disorders. Using shockwaves to stimulate the affected tissues, ESWT can promote tissue regeneration and improve blood supply.

Moreover, ESWT has also been explored as a treatment option for non-unions of long bone fractures and bone stress injuries, like medial tibial stress syndrome (MTSS). The potential to aid bone healing and promote tissue repair in these scenarios further adds to its therapeutic versatility.

The biological responses and molecular changes induced by ESWT are believed to be the key factors leading to its therapeutic effects. These changes can include the release of growth factors, increased blood flow, stimulation of stem cells, and enhanced tissue healing and regeneration.

While ESWT shows great promise as a non-invasive treatment modality, it’s essential to remember that its effectiveness may vary depending on individual patient factors and the specific condition being treated. As with any medical treatment, consulting with a qualified healthcare professional is crucial to determine the most appropriate course of action for each patient’s unique situation.